These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1309447)

  • 1. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
    Anderson FL; Port JD; Reid BB; Larrabee P; Hanson G; Bristow MR
    Circulation; 1992 Jan; 85(1):46-53. PubMed ID: 1309447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
    Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV
    J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
    Anderson FL; Port JD; Reid BB; Hanson G; Kralios AC; Hershberger RE; Bristow MR
    J Cardiovasc Pharmacol; 1992; 20(5):800-6. PubMed ID: 1280744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmural heterogeneity of norepinephrine uptake in failing human hearts.
    Beau SL; Saffitz JE
    J Am Coll Cardiol; 1994 Mar; 23(3):579-85. PubMed ID: 8113537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.
    Asano K; Dutcher DL; Port JD; Minobe WA; Tremmel KD; Roden RL; Bohlmeyer TJ; Bush EW; Jenkin MJ; Abraham WT; Raynolds MV; Zisman LS; Perryman MB; Bristow MR
    Circulation; 1997 Mar; 95(5):1193-200. PubMed ID: 9054849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts.
    Beau SL; Tolley TK; Saffitz JE
    Circulation; 1993 Dec; 88(6):2501-9. PubMed ID: 7902783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
    Bristow MR; Anderson FL; Port JD; Skerl L; Hershberger RE; Larrabee P; O'Connell JB; Renlund DG; Volkman K; Murray J
    Circulation; 1991 Sep; 84(3):1024-39. PubMed ID: 1653120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy.
    Movsesian MA; Bristow MR; Krall J
    Circ Res; 1989 Oct; 65(4):1141-4. PubMed ID: 2551528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart.
    Ogletree-Hughes ML; Stull LB; Sweet WE; Smedira NG; McCarthy PM; Moravec CS
    Circulation; 2001 Aug; 104(8):881-6. PubMed ID: 11514373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.
    Ungerer M; Böhm M; Elce JS; Erdmann E; Lohse MJ
    Circulation; 1993 Feb; 87(2):454-63. PubMed ID: 8381058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
    Bristow MR; Ginsburg R; Umans V; Fowler M; Minobe W; Rasmussen R; Zera P; Menlove R; Shah P; Jamieson S
    Circ Res; 1986 Sep; 59(3):297-309. PubMed ID: 2876788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    Eur J Clin Pharmacol; 1992; 42(6):607-11. PubMed ID: 1320570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy.
    Medina E; Sucharov CC; Nelson P; Miyamoto SD; Stauffer BL
    J Pediatr; 2017 Mar; 182():184-189.e1. PubMed ID: 27908653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy.
    Gilbert EM; Olsen SL; Renlund DG; Bristow MR
    Am J Cardiol; 1993 Mar; 71(9):23C-29C. PubMed ID: 8096672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
    Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR
    Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle.
    Parker JD; Newton GE; Landzberg JS; Floras JS; Colucci WS
    Circulation; 1995 Oct; 92(7):1793-800. PubMed ID: 7671363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
    Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
    Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy.
    White M; Yanowitz F; Gilbert EM; Larrabee P; O'Connell JB; Anderson JL; Renlund D; Mealey P; Abraham WT; Bristow MR
    Am J Cardiol; 1995 Dec; 76(17):1271-6. PubMed ID: 7503009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.